Sulfonyl containing compounds as cysteine protease inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 22, 2011
Grant Date -
Nov 20, 2008
app pub date -
Mar 22, 2006
filing date -
Mar 22, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully